Influence of prior pregnancies on disease course and cause of death in systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 61, Issue 4, 2002, Pages 346-350

  Artlett, C M ^a   Rasheed, M ^a   Russo Stieglitz, K E ^a   Sawaya, H H B ^a   Jimenez, S A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBON MONOXIDE;

ADULT; ARTICLE; CAUSE OF DEATH; CELL TRANSFER; CHIMERA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FETUS CELL; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; ONSET AGE; PATHOGENESIS; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SYSTEMIC SCLEROSIS; UNIVERSITY;

ADULT; AGE OF ONSET; AGED; ANTIBODIES, ANTINUCLEAR; CAUSE OF DEATH; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; REPRODUCTIVE HISTORY; SCLERODERMA, SYSTEMIC;

EID: 0036207919     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.4.346     Document Type: Article

References (43)

1. Pathogenesis of scleroderma: Collagen
2. Systemic sclerosis: A vascular perspective
3. Antinuclear antibody in systemic sclerosis (scleroderma)
4. Scleroderma-like graft-versus-host disease as late consequence of bone marrow grafting
5. Scleroderma, Sjögren-like syndrome and chronic graft-versus-host disease
6. New perspectives on the etiology of systemic sclerosis
7. Cellular infiltrates in scleroderma skin
8. Lymphoid infiltrates in skin in graft-versus-host disease
9. Cellular immune dysfunction and the pathogenesis of scleroderma
10. Interleukin-2 in scleroderma: Correlation of serum level with extent of skin involvement and disease duration
11. Cytokines and systemic sclerosis
12. Connective tissue metabolism including cytokines in scleroderma
13. Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man
14. Increased incidence of spontaneous abortion and infertility with scleroderma before disease onset: A controlled study
15. Scleroderma
16. Chimerism and autoimmunity
17. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
18. Maternal-fetal immunology and autoimmune disease: Is some autoimmune disease auto-alloimmune or allo-autoimmune?
19. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis
20. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma
21. Scleroderma CREST syndrome and pregnancy
22. Scleroderma and pregnancy
23. Scleroderma and pregnancy
24. Scleroderma and pregnancy
25. Scleroderma
26. Changes in cytokine production during and after pregnancy
27. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy
28. Synthesis of T helper 2-type cytokines at the maternal-fetal interface
29. Cytokine dysregulation and the initiation of systemic autoimmunity
30. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee
31. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
32. Progressive systemic sclerosis: Mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients
33. Pregnancy and scleroderma
34. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes
35. Immunological tolerance of the fetal allograft: Efficacy of immunotherapy and IL-4 and TNF alpha serum levels in recurrent abortion
36. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis
37. Maternal cell traffic in allogeneic embryos
38. Microchimerism in pregnant mice
39. Fetal cells in the maternal circulation: Detection of Y-sequence by gene amplification
40. Persistent fetal and maternal microchimerism: A new etiology for autoimmune disease?
41. Microchimerism of maternal origin persists into adult life
42. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies
43. Relationship between parity and clinical and biological features in patients with systemic sclerosis